WE
SEEL

Wealth Effects’s Seelos Therapeutics, Inc. Common Stock SEEL Stock Holding History

Wealth Effects’s Portfolio SEEL Stock Details SEEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-3,365
Closed -$32.1K – 226
2024
Q2 		$32.1K Sell
3,365
-281
-8% -$9.47K 0.01% 204
2024
Q1 		$276K Buy
3,646
+1,860
+104% +$245K 0.1% 160
2023
Q4 		$318K Buy
1,786
+847
+90% +$417K 0.12% 147
2023
Q3 		$663K Buy
939
+516
+122% +$2.21M 0.33% 74
2023
Q2 		$1.94M Buy
423
+174
+70% +$604K 0.85% 14
2023
Q1 		$661K Buy
+249
New +$729K 0.34% 71

Other funds holding SEEL

AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
MWM
Modera Wealth Management Westwood, New Jersey $8.34B AUM 19.68% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
CHA
Carmichael Hill & Associates Gaithersburg, Maryland $271M AUM 32.52% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $3.03B AUM 104.56% 1-Year Est. Return